Literature DB >> 23818191

Clinical trials in orthopaedics and the future direction of clinical investigations for femoroacetabular impingement.

John C Clohisy1, Young-Jo Kim, Jon Lurie, Siôn Glyn-Jones, Peter Wall, Rick Wright, Kurt Spindler, Stefan Lohmander.   

Abstract

Femoroacetabular impingement (FAI) represents a heterogeneous group of disorders that affect a diverse patient population. The natural history of the disease, the role of nonsurgical management, the indications for surgery, optimal surgical techniques, and the predictors of treatment outcomes need to be further defined. To date, clinical research reports have included primarily surgical case series. Future clinical investigations are needed to establish improved clinical evidence to guide patient care. Most urgent is the need to better understand the potential role of standardized nonsurgical treatment options for FAI and to define the predictors of surgical and nonsurgical outcomes. Future randomized controlled trials and large observational cohort studies targeted at these clinical research deficiencies will strengthen the evidence and improve informed decision making regarding the management of symptomatic FAI.

Entities:  

Mesh:

Year:  2013        PMID: 23818191     DOI: 10.5435/JAAOS-21-07-S47

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  2 in total

Review 1.  Surgical innovation and safety: femoroacetabular impingement and the IDEAL collaborative framework.

Authors:  Cara Beth Lee
Journal:  J Hip Preserv Surg       Date:  2015-12-03

2.  The feasibility of conducting a randomised controlled trial comparing arthroscopic hip surgery to conservative care for patients with femoroacetabular impingement syndrome: the FASHIoN feasibility study.

Authors:  D R Griffin; E J Dickenson; P D H Wall; A Realpe; A Adams; N Parsons; R Hobson; J Achten; M L Costa; N E Foster; C E Hutchinson; S Petrou; J L Donovan
Journal:  J Hip Preserv Surg       Date:  2016-11-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.